Vaccination of C57BL/10 mice against cutaneous leishmaniasis using killed promastigotes of different strains and species of Leishmania
Rev. Soc. Bras. Med. Trop
; Rev. Soc. Bras. Med. Trop;35(2): 125-132, Mar.-Apr. 2002. tab, graf
Article
em En
| LILACS
| ID: lil-327475
Biblioteca responsável:
BR1.1
ABSTRACT
Antigenic extracts from five Leishmania stocks were used to vaccinate C57BL/10 mice. The Leishvacin® and PH8 monovalent vaccine yielded the highest IFN-gamma levels in the supernatants of spleen cell culture from vaccinated animals. Each single strain immunized group showed evidence of protective immunity six months after the challenge with promastigotes of Leishmania (Leishmania) amazonensis. No differences were detected between the vaccinated groups. It can be concluded that vaccines composed of single Leishmania stocks can provide protection to C57BL/10 mice against L. (L.) amazonensis infection
Texto completo:
1
Coleções:
01-internacional
Base de dados:
LILACS
Assunto principal:
Vacinas Protozoárias
/
Vacinação
/
Leishmaniose Cutânea
/
Leishmania
Limite:
Animals
Idioma:
En
Revista:
Rev. Soc. Bras. Med. Trop
Assunto da revista:
MEDICINA TROPICAL
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Brasil